|
Extramural Support
|
RMS2013 [E]
|
$366,054,072
|
$415,564
|
N/A
|
National Cancer Institute
|
|
Modeling bladder cancer pathogenesis and tumor evolution
|
1P01CA221757-01A1
|
$1,765,498
|
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Linxian nutrition intervention trials - etiologic studies
|
ZIA CP000112-10339
|
$93,284
|
$46,642
|
Abnet, Christian
|
DCEG (NCI)
|
|
Gastric and Esophageal Malignancies in Northern Iran (GEMINI): Case-Control Study
|
ZIA CP000185-10318
|
$44,211
|
$44,211
|
Abnet, Christian
|
DCEG (NCI)
|
|
The Golestan Cohort Study
|
ZIA CP000185-10361
|
$27,523
|
$16,514
|
Abnet, Christian
|
DCEG (NCI)
|
|
The Thinker Study
|
ZIA CP000185-10464
|
$2,289
|
$2,289
|
Abnet, Christian
|
DCEG (NCI)
|
|
Center for Multiple Myeloma Nanotherapy
|
5U54CA199092-04
|
$2,184,301
|
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
Mesothelin as a biomarker for clinical management of esophageal adenocarcinoma
|
5R21CA164585-02
|
$186,970
|
$186,970
|
Adusumilli, Prasad
|
SLOAN-KETTERING INST CAN RES
|
|
Plumbagin in Combination with Vemurafenib for BRAF-mutant Melanoma
|
5R03CA212798-02
|
$74,250
|
|
AFAQ, FARRUKH
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Novel Combinatorial Therapeutic Approach for Prostate Cancer
|
5R03CA219336-02
|
$74,250
|
|
AFAQ, FARRUKH
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.
|
5R01CA195708-05
|
$382,616
|
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation
|
5R01CA197081-03
|
$470,573
|
|
AHMED, MUNEEB
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-10
|
$13,680
|
$137
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Participation in the Eastern Cooperative Oncology Group
|
7U10CA107868-11
|
$160,010
|
$1,600
|
AISNER, JOSEPH
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
Inhibition of Hedgehog Signaling in Gli-1+Adeno CA of the Esoph or GE junction
|
1R01CA172741-01A1
|
$279,793
|
$279,793
|
Ajani, Jaffer
|
UT MD ANDERSON CANCER CTR
|
|
Prediction of Pathologic Complete Response by Gene Expression Profiling in Esopha
|
5R01CA138671-04
|
$291,367
|
$291,367
|
Ajani, Jaffer
|
UT MD ANDERSON CANCER CTR
|
|
Title: Pre-clinical Evaluation of a Novel Immune Modulator, Alpha-TEA in Combination with Immune Checkpoint Blockade
|
1R43CA228721-01
|
$299,607
|
|
AKPORIAYE, EMMANUEL
|
VEANA THERAPEUTICS, LLC
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,207,080
|
$36,212
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Tumor Embolization Using A Novel Catheter With Integrated Flow Regulation
|
2R44CA192428-02A1
|
$893,847
|
|
ALLEN, MICHAEL
|
EMBOLX, INC.
|
|
Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer
|
5R01CA198074-04
|
$378,171
|
|
ALLEN, BENJAMIN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
|
5R01CA183811-05
|
$435,560
|
|
ALMAN, BENJAMIN
|
DUKE UNIVERSITY
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144-07130
|
$1,156,216
|
$23,124
|
Alter, Blanche
|
DCEG (NCI)
|
|
Bitter Melon Component and Colon Cancer Prevention
|
5R01CA190291-05
|
$544,710
|
|
ANANT, SHRIKANT
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
Metro-Minnesota Community Clinical Oncology Program (MM-CCOP)
|
5UG1CA189863-06
|
$2,840,966
|
|
ANDERSON, DANIEL
|
HEALTHPARTNERS INSTITUTE
|
|
Evaluation of centrosome amplification as a risk-predictor for breast cancer aggr
|
5U01CA179671-05
|
$303,118
|
|
ANEJA, RITU
|
GEORGIA STATE UNIVERSITY
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-27
|
$1,874,946
|
$18,749
|
Atkins, James
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Eastern Cooperative Oncology Group Studies
|
3U10CA014548-38S1
|
$334,918
|
$3,349
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Identifying predictors of racial disparity in treatment and mortality among patients diagnosed with breast cancer in South Carolina and geospatial investigation of breast cancer patient navigation
|
5F99CA222722-02
|
$39,707
|
|
BABATUNDE, OLUWOLE
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
|
Reducing Cancer Transcriptional Heterogeneity through Regulation of Chromatin Structure
|
1R01CA228272-01
|
$659,504
|
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
The Duke Preclinical Research Resources for Quantitative Imaging Biomarkers
|
5U24CA220245-02
|
$631,958
|
|
BADEA, CRISTIAN
|
DUKE UNIVERSITY
|
|
Improving Informal Caregivers and Cancer Survivors Psychological Distress, Symptom Management and Health Care Use
|
1R01CA224282-01A1
|
$650,204
|
|
BADGER, TERRY
|
UNIVERSITY OF ARIZONA
|
|
A Psychosocial Intervention for the Caregivers of Advanced Lung Cancer Patients
|
5R01CA187143-05
|
$456,456
|
|
BADR, HODA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Inter-relationship between microbiota diversity, obesity and race in endometrial cancer
|
5R21CA220269-02
|
$169,106
|
|
BAE-JUMP, VICTORIA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
SPORE in Bladder Cancer
|
1P50CA221745-01A1
|
$2,299,837
|
|
BAJORIN, DEAN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Tyrosine kinase inhibitors for the treatment of childhood AML
|
5R01CA138744-09
|
$343,388
|
|
BAKER, SHARYN
|
OHIO STATE UNIVERSITY
|
|
Obesity, related comorbidities, and breast cancer outcomes in African Americans
|
5R01CA185623-05
|
$1,038,141
|
|
BANDERA, ELISA
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
Implementation and Impact of Cancer Screening Navigation by Community Health Workers in Two National Screening Programs
|
1K01CA229996-01
|
$154,723
|
|
BARRINGTON, WENDY
|
UNIVERSITY OF WASHINGTON
|
|
Regulation of Ceramide-Based Therapeutics in Acute Myeloid Leukemia
|
5K22CA190674-04
|
$161,692
|
|
BARTH, BRIAN
|
UNIVERSITY OF NEW HAMPSHIRE
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-16
|
$320,126
|
$3,201
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Training Program in Nervous System Tumors
|
5K12CA090354-18
|
$805,200
|
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Targeting Mucin and EGFR Axis in Pancreatic Cancer
|
5R01CA183459-05
|
$311,659
|
|
BATRA, SURINDER
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Determining the Epigenetic Mechanisms Driving Tissue Factor (F3) Upregulation and its Role in Metastatic Osteosarcoma
|
5F31CA213965-02
|
$44,524
|
|
BAYLES, IAN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-29
|
$1,065,000
|
$10,650
|
Bearden, James
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
RNF128 Regulation of TP53 in Barretts Progression
|
5R01CA215596-02
|
$422,751
|
$422,751
|
BEER, DAVID
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Iowa-Wide Oncology Research Coalition (I-WORC)
|
5UG1CA189816-05
|
$1,177,581
|
|
BEHRENS, ROBERT
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
ECOG Clinical Trials
|
5U10CA017145-38
|
$362,638
|
$3,626
|
BENSON, AL
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Hawaii Minority-Based Clinical Community Oncology Program
|
5U10CA063844-20
|
$736,823
|
$7,368
|
Berenberg, Jeffrey
|
UNIVERSITY OF HAWAII AT MANOA
|
|
PSMA - Targeted Small-Molecule Drug Conjugates
|
1R21CA223121-01A1
|
$199,665
|
|
BERKMAN, CLIFFORD
|
WASHINGTON STATE UNIVERSITY
|
|
Eastern Cooperative Oncology Group
|
5U10CA049957-25
|
$291,047
|
$2,910
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MED CTR
|
|
Cancer and Leukemia Group B
|
5U10CA031946-32
|
$9,816,255
|
$98,163
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
Total relevant funding to Esophagus for this search: $28,902,473
|